Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.41%18.49B | -1.35%4.84B | -2.73%4.41B | -2.31%4.49B | 4.85%4.76B | 18.33%18.57B | 4.99%4.9B | 14.20%4.54B | 23.25%4.59B | 36.49%4.54B |
Operating revenue | -0.41%18.49B | -1.35%4.84B | -2.73%4.41B | -2.31%4.49B | 4.85%4.76B | 18.33%18.57B | 4.99%4.9B | 14.20%4.54B | 23.25%4.59B | 36.49%4.54B |
Cost of revenue | -4.67%16.46B | -11.87%4.06B | -8.78%3.96B | -5.01%3.99B | 8.02%4.46B | 32.32%17.27B | 9.50%4.6B | 26.06%4.34B | 50.85%4.2B | 57.48%4.13B |
Gross profit | 55.99%2.03B | 158.94%782M | 130.46%454M | 26.26%500M | -27.21%297M | -50.74%1.3B | -35.47%302M | -62.83%197M | -58.05%396M | -41.88%408M |
Operating expense | -4.80%2.3B | 14.29%608M | -1.74%509M | -15.07%569M | -12.16%614M | -22.38%2.42B | -37.49%532M | -26.11%518M | -17.49%670M | 350.97%699M |
Selling and administrative expenses | -11.14%2.35B | -3.44%617M | -3.35%549M | -16.74%572M | -19.01%605M | -16.57%2.64B | -23.93%639M | -25.65%568M | -14.13%687M | -1.71%747M |
-Selling and marketing expense | -11.43%969M | 8.40%271M | 2.16%237M | -18.73%230M | -29.48%232M | -13.45%1.09B | -24.47%250M | -30.75%232M | -8.12%283M | 13.45%329M |
-General and administrative expense | -10.94%1.38B | -11.05%346M | -7.14%312M | -15.35%342M | -10.77%373M | -18.64%1.55B | -23.58%389M | -21.68%336M | -17.89%404M | -11.06%418M |
Other operating expenses | 80.18%-44M | 91.59%-9M | 20.00%-40M | 82.35%-3M | 118.75%9M | -274.80%-222M | ---107M | ---50M | -241.67%-17M | 92.07%-48M |
Operating profit | 75.78%-270M | 175.65%174M | 82.87%-55M | 74.82%-69M | -8.93%-317M | -136.73%-1.12B | 39.95%-230M | -87.72%-321M | -307.58%-274M | -153.20%-291M |
Net non-operating interest income expense | 410.12%766M | 2.91%-100M | -71.83%-122M | -197.14%-104M | 3,045.95%1.09B | -135.24%-247M | -164.10%-103M | -153.57%-71M | -84.21%-35M | -94.74%-37M |
Other net income (expense) | ||||||||||
Special income (charges) | 95.25%-438M | 88.52%-304M | 101.98%5M | 100.76%48M | -327.27%-188M | -1,912.18%-9.22B | -2,979.07%-2.65B | ---253M | ---6.28B | ---44M |
-Less:Restructuring and merger&acquisition | -92.41%23M | 21.43%17M | --0 | -88.89%5M | -97.22%1M | 413.56%303M | -76.27%14M | --210M | --45M | --36M |
-Less:Other special charges | -89.82%272M | -93.18%144M | -133.33%-5M | -109.81%-53M | 2,237.50%187M | 549.24%2.67B | --2.11B | --15M | --540M | --8M |
-Write off | -99.52%27M | -93.16%27M | --0 | --0 | --0 | 20,666.67%5.61B | 1,362.96%395M | --0 | --5.21B | --0 |
Income before tax | 101.98%208M | 93.53%-192M | 80.30%-120M | 98.53%-97M | 270.44%617M | -3,337.85%-10.52B | -838.61%-2.97B | -375.78%-609M | -3,640.86%-6.59B | -162.09%-362M |
Income tax | 113.14%102M | 144.71%38M | -66.67%28M | 103.29%23M | 116.22%12M | -38,900.00%-776M | -28.79%-85M | 300.00%84M | -6,463.64%-700M | -174.00%-74M |
Net income | 101.09%106M | 92.02%-230M | 78.64%-148M | 97.96%-120M | 310.07%605M | -3,117.65%-9.75B | -1,052.40%-2.88B | -705.81%-693M | -3,463.43%-5.89B | -159.63%-288M |
Net income continuous Operations | 101.09%106M | 92.02%-230M | 78.64%-148M | 97.96%-120M | 310.07%605M | -3,117.65%-9.75B | -1,052.40%-2.88B | -705.81%-693M | -3,463.43%-5.89B | -159.63%-288M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 101.09%106M | 92.02%-230M | 78.64%-148M | 97.96%-120M | 310.07%605M | -3,117.65%-9.75B | -1,052.40%-2.88B | -705.81%-693M | -3,463.43%-5.89B | -159.63%-288M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 101.09%106M | 92.02%-230M | 78.64%-148M | 97.96%-120M | 310.07%605M | -3,117.65%-9.75B | -1,052.40%-2.88B | -705.81%-693M | -3,463.43%-5.89B | -159.63%-288M |
Basic earnings per share | 100.02%0.03 | 99.86%-0.05 | 99.66%-0.03 | 99.96%-0.03 | 106.25%0.23 | -3,117.19%-124.61 | -1,050.94%-36.83 | -704.55%-8.85 | -3,444.00%-75.24 | -159.35%-3.68 |
Diluted earnings per share | 100.02%0.03 | 99.86%-0.05 | 99.66%-0.03 | 99.96%-0.03 | 106.25%0.23 | -3,117.19%-124.61 | -1,050.94%-36.83 | -704.55%-8.85 | -3,458.93%-75.24 | -159.55%-3.68 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK | SEK |